Literature DB >> 15964076

Increased association of CD38 with lipid rafts in T cells from patients with systemic lupus erythematosus and in activated normal T cells.

Esther J Pavón1, Pilar Muñoz, María-del-Carmen Navarro, Enrique Raya-Alvarez, José-Luis Callejas-Rubio, Francisco Navarro-Pelayo, Norberto Ortego-Centeno, Jaime Sancho, Mercedes Zubiaur.   

Abstract

In this study we have determined whether there is a relationship between CD38 expression on T cells, its distribution in different membrane microdomains, and T cell activation in SLE patients. The data show that CD38 expression is augmented in ex vivo CD3+, CD4+, CD8+, and CD25+ SLE T cells, which correlates with its increased insolubility in Brij 98 detergent, and its translocation into lipid rafts. Moreover, SLE T cells show an altered CD4:CD8 ratio, which is due to a decreased proportion of CD4+ T cells and a concomitant increase in the proportion of CD8+ T cells. These data are consistent with the increased CD38 expression and lipid raft formation, and the significant reduction in the CD4:CD8 ratio observed in mitogen-stimulated normal T cells as compared with that in ex vivo untouched normal T cells. Increased expression of CD38 in floating rafts from SLE T cells, or from activated normal T cells may modulate TCR signaling by providing or sequestering signaling molecules to the engaged TCR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964076     DOI: 10.1016/j.molimm.2005.05.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

Review 1.  Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity.

Authors:  Frances E Lund
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 2.  CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity.

Authors:  Fabio Malavasi; Silvia Deaglio; Enza Ferrero; Ada Funaro; Jaime Sancho; Clara M Ausiello; Erika Ortolan; Tiziana Vaisitti; Mercedes Zubiaur; Giorgio Fedele; Semra Aydin; Elena V Tibaldi; Ilaria Durelli; Riccardo Lusso; Franco Cozno; Alberto L Horenstein
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 3.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

4.  Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells.

Authors:  Mohamed E M Saeed; Joelle C Boulos; Sabrina B Mücklich; Ellen Leich; Manik Chatterjee; Sabine M Klauck; Thomas Efferth
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

5.  Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Peter Szigligeti; Lisa Neumeier; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

6.  Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Lisa Neumeier; Koichi Takimoto; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  Cell Calcium       Date:  2009-12-02       Impact factor: 6.817

7.  Increased expression of ganglioside GM1 in peripheral CD4+ T cells correlates soluble form of CD30 in Systemic Lupus Erythematosus patients.

Authors:  Lingli Dong; Shaoxian Hu; Fang Chen; Xiaomei Lei; Wei Tu; Yikai Yu; Liu Yang; Wei Sun; Takuro Yamaguchi; Yasufumi Masaki; Hisanori Umehara
Journal:  J Biomed Biotechnol       Date:  2010-06-30

8.  Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.

Authors:  Franz Josef Gassner; Lukas Weiss; Roland Geisberger; Josefina Piñón Hofbauer; Alexander Egle; Tanja Nicole Hartmann; Richard Greil; Inge Tinhofer
Journal:  Cancer Immunol Immunother       Date:  2010-09-21       Impact factor: 6.968

9.  The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections.

Authors:  Eri Katsuyama; Abel Suarez-Fueyo; Sean J Bradley; Masayuki Mizui; Ana V Marin; Lama Mulki; Suzanne Krishfield; Fabio Malavasi; Joon Yoon; Shannan J Ho Sui; Vasileios C Kyttaris; George C Tsokos
Journal:  Cell Rep       Date:  2020-01-07       Impact factor: 9.423

10.  CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice.

Authors:  Jocelyn C Pérez-Lara; Enrique Espinosa; Leopoldo Santos-Argumedo; Héctor Romero-Ramírez; Gabriela López-Herrera; Fabio García-García; Claudia Sandoval-Montes; Vianney Ortiz-Navarrete; Mónica Flores-Muñoz; Juan C Rodríguez-Alba
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.